Clinical TrialDepressive DisordersPlaceboPlaceboCompleted

Psyrreal VR Psychedelic Replication Feasibility Study — Estonia 2021

TBD

Target Enrollment
14 participants
Study Type
Phase NA interventional
Design
Non-randomized

Detailed Description

TBD

Study Arms & Interventions

Control VR

placebo

A 5-minute demonstrative VR experience in a small room with a balcony view onto a mountain range, used as a control condition for comparisons with EDI, PIQ, and MEQ30 measures.

Interventions

  • Placebo
    single dose1 doses total

    5-minute demonstrative VR experience

Psyrreal VR

experimental

A 45-minute psychedelic-inspired virtual reality experience implementing various audiovisual and narrative phenomenological elements.

Interventions

  • Placebo
    single dose1 doses total

    45-minute VR experience implemented on the second day of a 2-day intervention

Study Details

  • Status
    Completed
  • Phase
    Phase NA
  • Type
    interventional
  • Design
    Non-randomized
  • Target Enrollment14 participants
  • Timeline
    Start: 2022-01-01
    End: 2022-01-01
  • Compounds
  • Topic

Locations

Estonia

Related Publications